Compound libraries
Products
EBC main page
Search
Impurities
Chemical probes
Contact
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
179324-69-7
Purity
95%
Bortezomib is a dipeptide boronic acid derivative and proteasome inhibitor. It used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies.
Properties
Name
Bortezomib
Smiles
CC(C)C[C@H](NC(=O)[C@H](CC=1C=CC=CC1)NC(=O)C=2C=NC=CN2)B(O)O
Targets
Please log in to see this information
SDS
BZM | Bortezomib | Btz | MG-341 | PS-341 | velcade
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
BZM | Bortezomib | Btz | MG-341 | PS-341 | velcade
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.